Table 1.
Presentation characteristics stratified by R-CHOP vs. R-bendamustine therapy.
| Population (n = 80) | R-CHOP (n = 49) | R-Bendamustine (n = 31) | p-Value |
|---|---|---|---|
| Median age, years (range) | 66 (52–77) | 70 (59–81) | 0.053 |
| Male/Female ratio | 1.0 (25:24) | 0.7 (13:18) | 0.428 |
| Median height, cm ± SD (range) | 166.2 ± 9.1 (150.0–189.0) | 167.5 ± 7.9 (150.0–184.0) | 0.498 |
| Median weight, kg ± SD (range) | 75.8 ± 21.2 (48.0–187.0) | 72.0 ± 14.2 (48.0–97.0) | 0.377 |
| Median BMI ± SD (range) | 22.9 ± 6.3 (16.0–56.7) | 21.4 ± 3.8 (14.8–28.8) | 0.227 |
| Grading | |||
| G1 | 4.2% (2/48) | 16.1% (5/31) | 0.241 |
| G1–G2 | 16.7% (8/48) | 16.1% (5/31) | |
| G2 | 47.9% (23/48) | 42.0% (13/31) | |
| G2–G3A | 6.2% (3/48) | 12.9% (4/31) | |
| G3A | 25.0% (12/48) | 12.9% (4/31) | |
| FLIPI s | |||
| Low | 2.1% (1/48) | 9.7% (3/31) | 0.322 |
| Intermediate | 58.3% (28/48) | 54.8% (17/31) | |
| High | 39.6% (19/48) | 35.5% (11/31) |
SD: standard deviation; BMI: body mass index; FLIPI: Follicular Lymphoma International Prognostic Index. Mann–Whitney test; Student’s t-test; Wilcoxon signed-rank tests.